Whether this year’s big job commitments sink or swim will be known in time. But for now, let’s explore the dreams.
Ozempic and Wegovy, made by Novo, are on track to become the world’s top-selling drugs by 2025. Yet in 2024, ‘Wegovy Wednesday’ had already become one of the biggest weight-loss trends to sweep the ...
Weight-loss medications surged in popularity this year. A survey from Kaiser Family Foundation found one in eight adults have taken drugs like Ozempic, Wegovy and Mounjaro. Demand for the drugs has ...
Not at all. Novo Nordisk's investigational weight loss therapy, CagriSema, combines semaglutide (the active ingredient in ...
Patients taking a compounded alternative to Eli Lilly's weight loss drug Zepbound will need to transition to the name-brand ...
Results for its new CagriSema drug, while promising, fell below expectations, sending shares of the pharmaceutical giant down ...
Eli Lilly and Novo Nordisk are the two biggest names in the pharmaceutical sector, but I see one as the clear-cut winner for ...
Unless the government intervenes to lower the price or forces insurers to cover the drugs, they will remain out of range for ...
Pennsylvania's Medicaid spending per enrollee on Wegovy, Zepbound, and other anti-obesity drugs was third-highest in the ...
DOGE co-chair Elon Musk shocked his followers on Christmas Day by posting a tweet of his trimmed-down self in a Santa outfit.
Tirzepatide may be more effective than semaglutide in helping people lose weight. At least that's the findings from recent ...